Some black Chicagoans looking to get into the industry voiced concerns about those firms having months to establish footholds in the expanded marketplace and potentially dominate the industry before other licenses are doled out to grow and sell the drug.
A largely unasked question is becoming glaring: Is Illinois doing all it should to use artificial intelligence to make government cost less and work better? So far, the evidence says no.